WO2026030303A1 - Medical device with integrated dressing pad - Google Patents

Abstract

Medical devices including an integrated dressing pad assembly. A medical device comprises a hypodermic needle having a distal tip configured to be inserted into a patient at an insertion location and a proximal end attached to a needle hub. An integrated dressing pad assembly is mounted to and positioned with respect the medical device or packaging so that the integrated dressing pad assembly is configured to be slidably engaged along the length of the hypodermic needle and applied to a patient at the insertion location when the medical device is used and the hypodermic needle is removed from the patient.

Description

MEDICAL DEVICE WITH INTEGRATED DRESSING PAD

TECHNICAL FIELD

[0001] The present disclosure generally relates to medical devices with an integrated dressing pad, including syringes and catheters for delivering fluids into patients and drawing fluids such as blood from a patient, including a hypodermic needle. More particularly, embodiments of the present disclosure relate to medical devices including a slidably mounted integrated dressing pad, which can be passively activated without activation by an administering medical practitioner or can be actively activated by activation by the administering medical practitioner.

BACKGROUND

[0002] Medical devices that include hypodermic needles such as syringes, catheters and other medical devices that include a hypodermic needle. Hypodermic needles have many applications. One application a hypodermic needle assembled to a syringe, which can be used to insert the hypodermic needle into a person's body for intramuscular, subcutaneous, or intravenous injection of medications. Another application is to collect blood samples for tests using a hypodermic needle attached to catheter body such as a winged catheter, which involves inserting a distal puncturing end of the hypodermic needle into a person's vein while an inverted rubber-capped vacuum tube is pushed into the barrel so that the other end of the needle pierces the rubber cap of the vacuum tube. Thus, a blood sample passes from the vein, through the hypodermic needle, and into the vacuum tube.

[0003] The use of a medical device including a hypodermic needle involves puncturing the skin of a patient, withdrawing the hypodermic needle from the patient, and then application of a wound dressing at the site of injection after the needle is removed from the patient. When a medical practitioner such as a doctor, nurse, phlebotomist, physician assistant, emergency medical technician, or paramedic applies a dressing, typically a bandage or a gauze wrapped with medical tape to the patient at the site of injection. A bandage requires opening of a separate package and peeling tabs from the adhesive bandage. Application of gauze and applying tape over the gauze requires opening a package of gauze, peeling tape from a roll and placement of the tape. Application of the dressing requires the medical practitioner to use two hands to open the packaging, apply the dressing and dispose the waste from the packaging. In a busy medical practice environment, these steps are time-consuming and require additional supplies that take up space in medical facilities and are responsible for additional waste that requires disposal. In addition, by placing the dressing manually at the injection site, there is a chance of error in placement of the dressing as the injection site location may become unclear after withdrawal of the hypodermic needle. Further, there is a lack of compliance in dressing placement and use after hypodermic needle withdrawal from a patient. There is a need to provide improvements in the application of dressing at site of insertion of the hypodermic needle upon removal of the hypodermic needle from the patient. It would be desirable to provide a more streamlined procedure for hypodermic needle injection retraction and dressing application to improve dressing application compliance without increasing the number of steps for the procedure.

SUMMARY

[0004] A first embodiment of the disclosure pertains to a medical device comprising a hypodermic needle having a distal tip configured to be inserted into a patient at an insertion location and a proximal end attached to a needle hub, the hypodermic needle having a length between the distal tip and the proximal end; and an integrated dressing pad assembly mounted to and positioned with respect the medical device or packaging for the medical device so that the integrated dressing pad assembly is configured to be slidably engaged along the length of the hypodermic needle and applied to a patient at the insertion location when the medical device is used and the hypodermic needle is removed from the patient.

[0005] A further aspect of the present disclosure pertains to an injection administration system comprising a robot arm configured to administer an injection and apply an integrated dressing pad assembly.

BRIEF DESCRIPTION OF THE DRAWINGS

[0006] Exemplary embodiments of the disclosure are further described in the following detailed description in conjunction with the accompanying drawings, in which: [0007] FIG. 1 is a side elevation view of a medical device comprising a hypodermic needle and an integrated dressing pad assembly mounted to and positioned with respect the medical device according to a first embodiment;

[0008] FIG. 2 is an isometric view of the integrated dressing pad assembly shown in FIG. 1 ;

[0009] FIG. 3 is partial a side cross-section view of the medical device shown in FIG. 1 ;

[0010] FIGS. 4A-C are side elevation views showing a first series of steps of a working sequence of use of the device shown in FIG. 1 removing the device from packaging;

[0011] FIGS. 4D-K are side elevation views showing a second series of steps of a working sequence of the device shown in FIG. 1 performing an injection;

[0012] FIGS. 4L-M are side elevation views showing a third series of steps of a working sequence of the device shown in FIG. 1 performing an injection;

[0013] FIGS. 5A-D are side elevation views of the medical device shown in FIG. 1 illustrating further features of the medical device;

[0014] FIG. 6 is an enlarged view of the passive needle shield portion of the medical device shown in FIG. 1 , showing the needle tip enveloped by the needle shield; and [0015] FIG. 7 is an enlarged top plan view of the passive needle shield portion of the medical device shown in FIG. 1 , showing the needle shield in a collapsed position, with the needle tip exposed;

[0016] FIG. 8 is an isometric view of a safety latch of the medical device shown in FIG. 1 ;

[0017] FIG. 9 is a side elevation view of the integrated dressing pad assembly of the medical device shown in FIG. 1 ;

[0018] FIG. 10 is an isometric view of the medical device shown in FIG. 1 ;

[0019] FIG. 11 is a side elevation view of a medical device comprising a hypodermic needle and an integrated dressing pad assembly mounted to and positioned with respect to the medical device according to a second embodiment;

[0020] FIG. 12 is an isometric view of a safety shield of the medical device shown in FIG. 11 ; [0021] FIG. 13 is an isometric view of the integrated dressing pad assembly of the medical device shown in FIG. 11 ;

[0022] FIGS. 14A-E are side elevation views of the medical device shown in FIG. 11 illustrating further features of the medical device;

[0023] FIG. 15 is an isometric view of the medical device shown in FIG. 11 ; and [0024] FIG. 16 is a side elevation view of a robot arm configured for use with any of the embodiments described herein of a medical device comprising a hypodermic needle and an integrated dressing pad assembly.

[0025] To facilitate understanding, identical reference numerals have been used, where possible, to designate identical elements that are common to the figures. The figures are not drawn to scale.

DETAILED DESCRIPTION

[0026] In this disclosure, a convention is followed wherein the distal end of the device is the end closest to a patient, e.g., for delivery of one or more drugs to the patient, and the proximal end of the device is the end away from the patient and closest to a clinician or other medical practitioner. With respect to terms used in this disclosure, the following definitions are provided.

[0027] As used herein, the use of "a," "an," and "the" includes the singular and plural. [0028] As used herein, the term "Luer connector" refers to a connection collar that is the standard way of attaching syringes, catheters, hubbed needles, LV. tubes, etc. to each other. The Luer connector consists of male and female interlocking tubes, slightly tapered to hold together better with even just a simple pressure/twist fit. Luer connectors can optionally include an additional outer rim of threading, allowing them to be more secure. The Luer connector male end is associated with a syringe discharge tip and can interlock and connect to the female end that is incorporated within a proximal end of a needle hub of a drug dispensing needle or filling needle for aspirating a drug from a drug vial into a syringe. Luer connector female ends are commonly located on vascular access devices (VADs).

[0029] As used herein, ISO 80369-7:2016 defines a specification for standard Luer connectors including a 6% taper between the distal end and the proximal end. A male standard Luer connector increases from the open distal end to the proximal end. A female standard Luer connector decreases from the open proximal end to the distal end. According to ISO 80369-7:2016, a male standard Luer connector has an outer cross-sectional diameter measured 0.75 mm from the distal end of the tip of between 3.970 mm and 4.072 mm. The length of the male standard Luer taper is between 7.500 mm to 10.500 mm. The outer cross-sectional diameter measured 7.500 mm from the distal end of the tip is between 4.376 mm and 4.476 mm. As used herein, the phrases "male standard Luer connector" and "female standard Luer connector" shall refer to connectors having the dimensions described in ISO 80369-7, which is hereby incorporated by reference in its entirety.

[0030] As would be readily appreciated by skilled artisans in the relevant art, while descriptive terms such as "tip", "hub", "thread", "protrusion/insert", "tab", "wall", "top", "side", "bottom" and others are used throughout this specification to facilitate understanding, it is not intended to limit any components that can be used in combinations or individually or to require specific spatial orientations, to implement various aspects of the embodiments of the present disclosure.

[0031] Before describing several exemplary embodiments of the disclosure, it is to be understood that the disclosure is not limited to the details of construction or process steps set forth in the following description. The disclosure is capable of other embodiments and of being practiced or being conducted in many ways.

[0032] The matters exemplified in this description are provided to assist in a comprehensive understanding of exemplary embodiments of the disclosure. Accordingly, those of ordinary skill in the art will recognize that various changes and modifications of the embodiments described herein can be made without departing from the scope and spirit of the disclosure. Also, descriptions of well-known functions and constructions are omitted for clarity and conciseness.

[0033] The following non-limiting examples demonstrate principles according to one or more embodiments of the disclosure.

[0034] According to one or more embodiments, a medical device 100, comprising a hypodermic needle and an integrated dressing pad assembly 110 are provided and described with respect to FIGS. 1-15. A medical device 100 comprising a hypodermic needle according to one or more embodiments includes, without limitation, syringes and catheter assemblies which include a hypodermic needle 102 configured to puncture the skin of patient to deliver fluid, e.g., medicine, a nutrient (e.g., dextrose 5% in water (D5W)) saline, etc.) or to withdraw blood or tissue (e.g., bone marrow) from a patient. According to the various embodiments provided herein, the medical device 100 comprises a hypodermic needle 102 having a distal tip 103 configured to be inserted into a patient at an insertion location and a proximal end attached to a needle hub 104, the hypodermic needle 102 having a length between the distal tip 103 and the proximal end. The medical device 100 according to one or more embodiments described herein further comprises an integrated dressing pad assembly 110 mounted to and positioned with respect the medical device 100 or packaging for the medical device 100 so that the integrated dressing pad assembly 110 is configured to be slidably engaged along the length of the hypodermic needle 102 and applied to a patient at the insertion location when the medical device 100 is used and the hypodermic needle 102 is removed from the patient. In one or more embodiments of the medical device 100 described herein, the integrated dressing pad assembly 110 comprises a dressing pad housing 112 assembled to a dressing pad.

[0035] Referring now to FIGS. 1-10, a first embodiment of medical device 100 comprising a hypodermic needle 102 having a distal tip 103 configured to be inserted into a patient at an insertion location and a proximal end 101 attached to a needle hub 104 is shown. In one or more embodiments, the hypodermic needle 102 has a length between the distal tip 103 and the proximal end 101. FIG. 1 is a side elevation view of the medical device 100 comprising the hypodermic needle 102 and the integrated dressing pad assembly 110 mounted to and positioned with respect the medical device 100, and FIG. 2 is an isometric view of the integrated dressing pad assembly 110 shown in FIG. 1.

[0036] The medical device 100 shown in FIGS. 1-10 further comprises an integrated dressing pad assembly 110 mounted to and positioned with respect the medical device 100 so that the integrated dressing pad assembly 110 is configured to be slidably engaged along the length of the hypodermic needle 102 and applied to a patient at the insertion location when the medical device 100 is used and the hypodermic needle 102 is removed from the patient. In the embodiment shown in FIGS. 1-10, the integrated dressing pad assembly 110 comprises a dressing pad housing 112 assembled to a dressing pad 1 14. [0037] As shown in FIGS. 1-10, and with particular reference to FIGS. 2-3, and 9, the integrated dressing pad housing 112 comprises a ring-shaped element including a central opening 113, and the integrated dressing pad 114 comprises a ring-shaped pad including a flared central opening 115 having a narrowed proximal portion 115p extending through the central opening 113 of the dressing pad housing 112 fitted within the central opening 113 of the integrated dressing pad housing 112. As best shown in FIG. 3, which is a partial side cross-section view of the medical device 100 shown in FIG. 1 , FIG. 3 shows the interaction of the hypodermic needle 102 with the flared central opening 115 fitted within the central opening 113 of the integrated dressing pad housing 112. The integrated dressing pad housing 112 comprises a ring-shaped element including a central opening 113 and the integrated dressing pad comprises a ringshaped pad including a flared central opening 115 having a narrowed proximal portion. The flared central opening 115 provides a frustoconical opening in which the narrowed proximal portion 115p has a smaller diameter than the distal portion 115d of the flared central opening 115. In one or more embodiments, the medical device 100 comprises a safety needle including a shield. An example of such a safety needle is the BD SafetyGlide™ needle solutions/products/product-families/bd-safetyglide-shieldinq-hypodermic-needle ).

[0038] The medical device 100 of the first embodiment further comprises a needle safety shield 120 slidably engaged with the hypodermic needle 102 and positioned between the needle hub 104 and the integrated dressing pad assembly 110.

[0039] Referring now to FIGS. 4A-C, which are side elevation views showing a first series of steps of a working sequence of use of the medical device 100 shown in FIG. 1 and removing the medical device 100 from a package 140 are shown. As shown in FIGS. 4A and 4B, the medical device 100 including a needle safety shield 120 is removed from a package 140. The package 140 can be any suitable packaging such as a hollow container, a blister package, or a tray. In FIG. 4C, the medical device including the needle safety shield 120 is ready for use. Referring now to FIGS. 4D-M, which are side elevation views showing a second series of steps of a working sequence of the device shown in FIG. 1 performing an injection. In FIG. 4D, the medical device 100 is shown adjacent to the injection site 200, for example, a patient's skin surface on their hand, arm, leg, or other location on the body where a medication, or fluid is delivered or withdrawn from a patient. In FIG. 4E, the device is shown contacting the injection site 200, and in FIG. 4F, the device, including the integrated dressing pad assembly 110 has been inserted at the injection site 200, and the integrated dressing pad assembly 110 is pressed up against the skin of the patient at the injection site.

[0040] Referring now to FIG. 4G and FIG. 4H, after injection has been completed, the practitioner applies a force in a distal direction to the integrated dressing pad assembly 110, for example by sliding the needle safety shield 120 in a distal direction on the hypodermic needle 102 and towards the injection site as indicated by the arrows in FIG. 4G and FIG. 4H.

[0041] Referring now to FIGS. 4I-K, as the practitioner withdraws the needle hub 104, which may be attached to a syringe, by pulling the needle hub 104 away from the patient by application of force in the proximal direction, the hinge 123 on the needle safety shield 120 folds from an elevated position in which a distal arm 122 and a proximal arm 121 of needle safety shield 120 are raised. By applying the proximal force to the hub, the hinge moves to a lowered position as shown in FIG. 4K, in which the distal arm 122 and the proximal arm 121 are extended to a flat position.

[0042] Referring now to FIGS. 4L and 4M, continued application of a force in the proximal direction with the needle safety shield 120 in an activated position to cover the hypodermic needle 102 of the hypodermic needle 102, the integrated dressing pad assembly is accurately applied at the site of injection. In some embodiments, the entire integrated dressing pad assembly 110 is applied at the site of injection, including the integrated dressing pad housing 112 and the integrated dressing pad. In other embodiments, only the integrated dressing pad 114 is applied at the injection site.

[0043] As can be seen from FIGS. 4A-M, the needle safety shield 120 comprises a proximal end adjacent and connected to the needle hub 104 and a distal end engaged with the integrated dressing pad housing 112, and the needle safety shield 120 is configured to slidably move along the length of the hypodermic needle 102 together with the integrated dressing pad assembly 110.

[0044] Referring to FIGS. 5A-D and 6-10, the distal end of the needle safety shield 120 comprises flexible protrusions 117, 119 for example a pair of flexible protrusions 117, 119shown best in FIG. 3, FIG. 7 and FIG. 10 as a first flexible protrusion 117 and a second flexible protrusion 119 that engage a peripheral rim defining the central opening 113 of the integrated dressing pad housing 112 and that are releasably secured to the integrated dressing pad housing 112 and are configured to be released when a pulling force in a proximal direction is applied to the needle safety shield 120. As shown in FIGS 5A-B, 7 and 10, in some embodiments the flexible protrusions 117, 119 are in the form of curved arms that have ends that engage the peripheral rim of the integrated dressing pad housing 112 and are wedged between the peripheral rim and the flared central opening 115 of the integrated dressing pad. The flexible protrusions 117, 119 are configured to deflect upon application of the pulling force in the proximal direction when a predetermined pulling force (e.g., 1 pound of force) is applied to the needle hub 104, causing the flexible protrusions 117, 119 to deflect and slide out from the central opening 113 of the integrated dressing pad housing 112. Thus, the flexible protrusions 117, 119 hold the integrated dressing pad 114 and is configured to cause passive activation of the needle safety shield 120 and to release the integrated dressing pad 114 once the shield has been activated.

[0045] As shown in FIGS. 5C and 5D and FIG. 7, when the hypodermic needle 102 has been withdrawn from the injection site, the medical device 100 including the hypodermic needle 102 and the needle safety shield 120 are discarded, while the dressing pad 114 remains adhered to the patient at the injection site. In one or more embodiments, the integrated dressing pad 114 comprises an adhesive configured to secure the integrated dressing pad 114 to the patient at the injection site and at least one of an antimicrobial agent and a hemostatic agent. In some embodiments, the integrated dressing pad 114 comprises both an antimicrobial agent and a hemostatic agent.

[0046] Referring to FIG. 6 and FIG. 8, the needle safety shield 120 further comprises a needle distal tip cover 125, which may be in the form of a plastic or metal clip with a distal bend 125d that is configured to cover the distal tip 103 of the hypodermic needle 102 after the safety shield 120 has been activated. The needle distal tip cover 125 cover may further comprise a mounting feature 127, as shown in FIG. 8, which may be in the form of an opening configured to be snap fit to a post or peg on the needle safety shield 120.

[0047] Referring now to FIGS. 11 -15, a second embodiment of a medical device 100 comprises a hypodermic needle 102 having a hypodermic needle 102 configured to be inserted into a patient at an insertion location and a proximal end attached to a needle hub 104, and an integrated dressing pad assembly 110 mounted to and positioned with respect the medical device 100 or packaging for the medical device 100 so that the integrated dressing pad assembly 110 is configured to be slidably engaged along the length of the hypodermic needle 102 and applied to a patient at the insertion location when the medical device 100 is used and the hypodermic needle 102 is removed from the patient.

[0048] Referring first to FIG. 11 , which shows a side elevation view of a medical device 100 comprising a hypodermic needle 102 and an integrated dressing pad assembly 110 mounted to and positioned with respect the medical device 100. a needle safety shield 120 configured to fold from open position in which the hypodermic needle 102 of the hypodermic needle 102 is exposed to a closed position that covers the distal tip 103 of the hypodermic needle 102 and comprising a connecting element extending from the needle safety shield 120 and connected to the integrated dressing pad.

[0049] As shown in FIG. 11 , a needle safety shield 220 is configured to fold from open position in which the distal tip 103 of the hypodermic needle 102 is exposed to a closed position that covers the distal tip 103 of the hypodermic needle 102. A nonlimiting example of such a needle safety shield 120 is utilized on a BD Eclipse™ Needle eclipse-needle). The needle safety shield 220 according to the second embodiment is pivotally mounted to the needle hub 104. FIG. 12 shows an isometric view of a second embodiment of the needle safety shield 220 of the medical device 100 shown in FIG. 11 . An underside of the needle safety shield 220 includes a sliding track 222.

[0050] The medical device 100 further comprises a connecting element 230 extending from the needle safety shield and connected to the integrated dressing pad, as best shown in FIG. 13, which shows a recess 214r or divot in the peripheral surface of the integrated dressing pad 214 and a second end of the connecting element 230 is inserted into the recess or divot. This arrangement provides a breakable connection between the integrated dressing pad 214and the connecting element 230. Other ways of providing a breakable connection in alternative embodiments can be utilized, such as a breakable bond between the second end and the integrated dressing pad. On the first end of the connecting element 230, a sliding element 232 in the form of a rod that forms a "T" shape at the top of the connecting element 230 is slidably engaged with the sliding track 222 on the needle safety shield 220.

[0051] Thus, the connecting element 230 includes a proximal end pivotally connected to the needle hub 104 and the connecting element 230 and the integrated dressing pad 214 are configured to slide along the length of the hypodermic needle 102 as the needle safety shield 220 is moved from an open position to the closed position. In some embodiments, the integrated dressing pad 214 comprises an adhesive configured to secure the integrated dressing pad 214 to the patient at the injection site and at least one of an antimicrobial agent and a hemostatic agent. The connecting element 230 is removably connected to the dressing pad 214 and configured to release from the integrated dressing pad 214 when the integrated dressing pad 214 adheres to the patient at the injection site 200 and the needle safety shield 220 is moved to the closed position.

[0052] FIGS. 14A-E show side elevation views of the medical device 100 shown in FIG. 11 illustrating use of the medical device 100. FIG. 14A shows the medical device 100 in the initial position. FIG. 14B shows the medical device 100 with the hypodermic needle 102 inserted at the injection site 200. In FIGS. 14A and 14B, the needle safety shield 220 is flipped upward, and the hypodermic needle 102 in the exposed position. As best shown in FIG. 15, the sliding element of the connecting element 230 is at the proximal end of the sliding track 222.

[0053] Referring now to FIG. 14C, as the hypodermic needle 102 is removed from the injection site 200, the medical device 100 is pulled away from the injection site 200 by application of a force in the proximal direction. It will be appreciated that the hypodermic needle 102 and needle hub are not shown as being connected to a medical device 100 to better illustrate the features of the needle safety shield and the connecting element 230. In one or more embodiments, the medical device 100 would include a syringe, a catheter adapter or other medical device 100 connected to the proximal end of the needle hub 104.

[0054] As the needle hub 104 and hypodermic needle 102 are withdrawn from the injection side, the sliding element slides along the sliding track towards the distal end of the pivotally mounted needle shield as shown in FIG. 14C. When the needle shield is folded over the hypodermic needle 102, the distal end of the connecting element 230 has disconnected the from the integrated dressing pad. FIG. 14D shows the state of the medical device 100 where the connecting element 230 is at the point where the connecting element 230 disconnects from the integrated dressing pad 214. FIG. 14E shows the needle safety shield 220 in the closed position.

[0055] Thus, in the second embodiment, the needle safety shield is configured to fold from open position in which the distal tip 103 of the hypodermic needle 102 is exposed to a closed position that covers the distal tip 103 of the hypodermic needle 102 and comprising a connecting element 230 extending from the needle safety shield and connected to the integrated dressing pad. The connecting element 230 includes a proximal end pivotally connected to the needle hub 104 and the connecting element 230 and the integrated dressing pad 1 Mare configured to slide along the length of the hypodermic needle 102 as the needle safety shield is moved from an open position to the closed position. In some embodiments, the integrated dressing pad 114 comprises an adhesive configured to secure the integrated dressing pad 114 to the patient at the injection site and at least one of an antimicrobial agent and a hemostatic agent. The connecting element is removably connected to the dressing pad 114 and configured to release from the integrated dressing pad 114when the integrated dressing pad 114 adheres to the patient at the injection site and the needle safety shield is moved to the closed position and covering the hypodermic needle.

[0056] Referring now to FIG. 16, an injection administration system is shown which can be used with any of the medical device 100 embodiments described herein. An injection administration system thus comprises the hypodermic needle 102 having the distal tip 103 configured to be inserted into a patient at an insertion location and a proximal end attached to a needle hub 104, the hypodermic needle 102 having a length between the distal tip 103 and the proximal end. The medical device 100 further comprises the integrated dressing pad assembly (not shown) mounted to and positioned with respect the medical device 100 or packaging for the medical device 100 so that the integrated dressing pad assembly is configured to be slidably engaged along the length of the hypodermic needle 102 and applied to a patient at the insertion location when the medical device 100 is used, and the hypodermic needle 102 is removed from the patient. The integrated dressing pad assembly of some embodiments comprises a dressing pad housing assembled to a dressing pad as shown in FIGS. 1-13. As shown in FIG. 16, a robot 300 includes a robot arm including a first arm portion 302, a second arm portion 304, and a gripping element 310 attached to the second arm portion, configured to administer an injection to a subject using an embodiment of the medical devices 100 described herein and apply an integrated dressing pad assembly 110 according to one or more embodiments. The robot arm 304 is configured to move about a first pivot point 303 joining the first arm portion and the second arm portion 314 and a second pivot point 305.

[0057] Advantageously, one or more embodiments of the medical device 100 described herein integrate the dressing pad 114 with the medical device 100, which facilitates accurate placement of the dressing pad 114 and greater compliance to application of the dressing because the integrated dressing pad assembly 110 is integral with the medical device 100. Also, practitioner workflow is simplified because the number of steps to apply a dressing is reduced and there is less packaging and materials needed to apply a dressing to the injection site. The integrated dressing pad assembly 110 can be utilized with both passive and active safety mechanisms to ensure dressing pad 114 placement after a patient has been injected. In certain embodiments, a practitioner can complete the injection and apply the dressing pad 114 using a single hand, while some embodiments may require the practitioner to use both hands. The integrated dressing pad assembly 110 can be utilized with various needle safety devices, including syringes as well as catheters.

[0058] Reference throughout this specification to "one embodiment," "certain embodiments," "various embodiments," "one or more embodiments" or "an embodiment" means that a particular feature, structure, material, or characteristic described in connection with the embodiment is included in at least one embodiment of the disclosure. Thus, the appearances of the phrases such as "in one or more embodiments," "in certain embodiments," "in various embodiments," "in one embodiment" or "in an embodiment" in various places throughout this specification are not necessarily referring to the same embodiment of the disclosure. Furthermore, the particular features, structures, materials, or characteristics may be combined in any suitable manner in one or more embodiments.

[0059] Although the disclosure herein provided a description with reference to particular embodiments, it is to be understood that these embodiments are merely illustrative of the principles and applications of the disclosure. It will be apparent to those skilled in the art that various modifications and variations can be made to the present disclosure without departing from the spirit and scope thereof. Thus, it is intended that the present disclosure include modifications and variations that are within the scope of the appended claims and their equivalents.

Claims

What is claimed is:

1 . A medical device, comprising: a hypodermic needle having a distal tip configured to be inserted into a patient at an insertion location and a proximal end attached to a needle hub, the hypodermic needle having a length between the distal tip and the proximal end; and an integrated dressing pad assembly mounted to and positioned with respect the medical device or packaging for the medical device so that the integrated dressing pad assembly is configured to be slidably engaged along the length of the hypodermic needle and applied to a patient at the insertion location when the medical device is used and the hypodermic needle is removed from the patient.

2. The medical device of claim 1 , wherein the integrated dressing pad assembly comprises a dressing pad housing assembled to a dressing pad.

3. The medical device of claim 2, wherein the integrated dressing pad housing comprises a ring-shaped element including a central opening and the integrated dressing pad comprises a ring-shaped pad including a flared central opening having a narrowed proximal portion fitted within the central opening of the integrated dressing pad housing.

4. The medical device of claim 3, further comprising a needle safety shield slidably engaged with the hypodermic needle and positioned between the needle hub and the integrated dressing pad assembly.

5. The medical device of claim 4, wherein the needle safety shield comprises a proximal end adjacent to the needle hub and a distal end engaged with the integrated dressing pad housing, and the needle safety shield is configured to slidably move along the length of the hypodermic needle together with the integrated dressing pad assembly.

6. The medical device of claim 4, wherein the distal end of the needle safety shield comprises flexible protrusions that engage the central opening of the integrated dressing pad housing and that are releasably secured to the integrated dressing pad housing and are configured to be released when a pulling force in a proximal direction is applied to the needle safety shield.

7. The medical device of claim 6, wherein the integrated dressing pad comprises an adhesive configured to secure the integrated dressing pad to the patient at an injection site and at least one of an antimicrobial agent and a hemostatic agent.

8. The medical device of claim 6, wherein the needle safety shield comprises a hinged arm having a proximal end connected to the needle hub.

9. The medical device of claim 8, wherein application of the pulling force in a proximal direction activates the needle safety shield to move in a distal direction to cover the distal tip of the hypodermic needle.

10. The medical device of claim 1 , further comprising a needle safety shield configured to fold from open position in which the distal tip of the hypodermic needle is exposed to a closed position that covers the distal tip of the hypodermic needle and comprising a connecting element extending from the needle safety shield and connected to the integrated dressing pad.

11. The medical device of claim 10, wherein the connecting element includes a proximal end pivotally connected to the needle hub and the connecting element and the integrated dressing pad are configured to slide along the length of the hypodermic needle as the needle safety shield is moved from an open position to the closed position.

12. The medical device of claim 11 , wherein the integrated dressing pad comprises an adhesive configured to secure the integrated dressing pad to the patient at an injection site and at least one of an antimicrobial agent and a hemostatic agent.

13. The medical device of claim 12, wherein the connecting element is removably connected to the dressing pad and configured to release from the integrated dressing pad when the integrated dressing pad adheres to the patient at the injection site and the needle safety shield is moved to the closed position.

14. An injection administration system comprising: a medical device according to claim 1 ; and a robot arm comprising a gripping element configured to administer an injection and apply an integrated dressing pad assembly.